PLoS ONE (Jan 2020)

Discrimination of biofilm-producing Stenotrophomonas maltophilia clinical strains by matrix-assisted laser desorption ionization-time of flight.

  • Edeer Montoya-Hinojosa,
  • Paola Bocanegra-Ibarias,
  • Elvira Garza-González,
  • Óscar Manuel Alonso-Ambriz,
  • Gabriela Aimee Salazar-Mata,
  • Licet Villarreal-Treviño,
  • Eduardo Pérez-Alba,
  • Adrián Camacho-Ortiz,
  • Rayo Morfín-Otero,
  • Eduardo Rodríguez-Noriega,
  • Samantha Flores-Treviño

DOI
https://doi.org/10.1371/journal.pone.0244751
Journal volume & issue
Vol. 15, no. 12
p. e0244751

Abstract

Read online

Stenotrophomonas maltophilia is a Gram-negative drug-resistant pathogen responsible for healthcare-associated infections. The aim was to search for biomarker peaks that could rapidly detect biofilm production in S. maltophilia clinical isolates obtained from two tertiary care hospitals in Mexico. Isolates were screened for the presence of biofilm-associated genes, in which the fsnR gene was associated with biofilm production (p = 0.047), whereas the rmlA+ genotype was associated with the rpfF- genotype (p = 0.017). Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectra comparison yielded three potential biomarker peaks (4661, 6074, and 6102 m/z) of biofilm-producing rmlA+ and rpfF- genotypes with >90% sensitivity (p<0.001). MALDI-TOF MS analyses showed a correlation between the relative abundance of 50S ribosomal proteins (L30 and L33) and the presence of the fnsR, rmlA and rpfF-2 genes, suggested to play a role in biofilm formation. Isolates obtained in the intensive care unit showed low clonality, suggesting no transmission within the hospital ward. The detection of biomarkers peaks by MALDI-TOF MS could potentially be used to early recognize and discriminate biofilm-producing S. maltophilia strains and aid in establishing appropriate antibiotic therapy.